- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05956106
Effect of Mulberry Fruit Powder in Metabolic Syndrome
Therapeutic Effect of Mulberry Fruit Powder Consumption in Metabolic Syndrome
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Metabolic syndrome, which is characterized by a number of concurrent risk factors. These risk factors include dysglycemia, high blood pressure, high triglyceride levels, low levels of HDL cholesterol, and obesity (particularly central adiposity). It is rapidly increasing the burden of non-communicable diseases (NCDs) in Pakistan. The prevalence of MetS in Pakistan is 28.6%, and suburban areas from the province of Punjab showed a high prevalence. Females are more prone to metabolic syndrome. Dietary and lifestyle modification can prevent MetS from converting into CVD, T2DM, and stroke. There is limited documented research in Pakistan related to the therapeutic roles of mulberry fruit powder. With respect to these limitations, the present study aims to assess the therapeutic roles of mulberry fruit powder consumption on metabolic syndrome.
The utilization of dried mulberry fruit powder (MFP) as a component of nutritional supplementation will effectively ameliorate the clinical markers associated with metabolic syndrome.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Fiza Maqbool, DNS
- Phone Number: 03008077414
- Email: fizach65@gmail.com
Study Locations
-
-
Punjab
-
Arifwala, Punjab, Pakistan, 57450
- Recruiting
- Shan Medicare Hospital
-
Contact:
- Dr. Muhammad Illyas, FCPS
- Phone Number: +923075055198
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Subjects having fasting total cholesterol level of ≥ 200 mg/dl or LDL cholesterol ≥ 130 mg/dl.
- Fasting Blood Glucose ≥110mg/dl.
- SBP ≥ 130/ ≥ 85 mmHg
- Waist Circumference of ≥40 inches in males and ≥35 inches for females
Exclusion Criteria:
- Participants of age 55 or above
- Participants who have less than two risk factors
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Metabolic syndrome patients
Dried Mulberry fruit powder is used for preventing symptoms in Metabolic Syndrome patients Dietary intervention: Black Mulberry fruit powder Dosage: 45g per day
|
Anthocyanin plays a major role in preventing symptoms of metabolic syndrome.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fasting glucose level will be assessed before and after the trial
Time Frame: 45 days
|
The change in fasting glucose levels will be assessed after consuming mulberry fruit powder for 45 days.The values will be become close to optimized levels
|
45 days
|
Weight circumference will be measured before and after the trial
Time Frame: 45 days
|
The change in weight will be measured after consuming mulberry fruit powder for 45 days.The value will be close to normal range.
|
45 days
|
Lipid profile will be assessed before and after the trial.
Time Frame: 45 days
|
The change in lipid profile, after consuming mulberry fruit powder for 45 days, will be assessed.
The value will be closed to optimized values.
|
45 days
|
Blood pressure will be assessed before and after the trial.
Time Frame: 45 days
|
The change in systolic and diastolic blood pressure, after consuming mulberry fruit powder for 45 days.
The values will become close to optimized levels.
|
45 days
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Mulberry Fruit Powder
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metabolic Syndrome
-
Universidad de los Andes, ChileCompleted
-
Taipei Medical University WanFang HospitalUnknownMetabolic Cardiovascular SyndromeTaiwan
-
SanofiBristol-Myers SquibbCompletedMetabolic Syndrome xUnited States
-
Mayo ClinicCompleted
-
Jordan Collaborating Cardiology GroupCardiovascular Academy; The Association of Jordanian Medical Laboratory Specialists...Not yet recruitingCardiovascular-renal-metabolic SyndromeJordan
-
University of HohenheimGerman Federal Ministry of Education and ResearchCompleted
-
The Catholic University of KoreaCompletedMetabolic Syndrome X | Metabolic Cardiovascular Syndrome | Insulin Resistance Syndrome X | Dysmetabolic Syndrome XKorea, Republic of
-
Charite University, Berlin, GermanyRecruitingMetabolic Syndrome, Protection AgainstGermany
-
Wageningen University and ResearchPhilips Healthcare; TNO; Friesland Campina; Albert Heijn; Menzis; Smart with food; Vi... and other collaboratorsCompletedMetabolic Syndrome, Protection AgainstNetherlands
-
Cairo UniversityCompletedMetabolic Syndrome in WomenEgypt
Clinical Trials on Black Mulberry Fruit Powder
-
Unilever R&DLambda Therapeutic Research Ltd.Completed
-
Seoul St. Mary's HospitalRural Development Administration, KoreaCompletedOxidative StressKorea, Republic of
-
Chulalongkorn UniversityCompletedObesity | Type 2 Diabetes MellitusThailand
-
Unilever R&DLambda Therapeutic Research Ltd.Completed
-
University of CincinnatiActive, not recruitingOverweight, Obesity and Other Hyperalimentation (E65-E68)United States
-
Chung Shan Medical UniversityTCI Co., Ltd.Recruiting
-
Mashhad University of Medical SciencesCompletedNausea | VomitingIran, Islamic Republic of
-
TCI Co., Ltd.Recruiting
-
Vital Solutions Swiss AGCompletedCardiovascular Disease | Metabolism | MicrocirculationGermany